Biotechnology News

March 27, 2014

NIJMEGEN, the Netherlands--(BUSINESS WIRE)--Synthon announces the company’s glatiramer acetate met the main endpoint of a late-stage PhIII study in patients with relapsing remitting multiple sclerosis (RRMS).

March 27, 2014

HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories (NYSE: RDY) announced today that it has launched Amlodipine Besylate and Atorvastatin Calcium Tablets 2.5/10mg, 2.5/20mg, 2.5/40mg, 5/10mg, 5/20mg, 5/40mg, 5/80mg, 10/10mg, 10/20mg, 10/...

March 27, 2014

GARGRAVE, England--(BUSINESS WIRE)--WOUNDCHEK™ Laboratories secures new financing and announces the newly formed WOUNDCHEK™ Laboratories Holdings Inc.

March 26, 2014

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Quintiles Announces Exercise of the Underwriters’ Option to Purchase Additional Secondary Shares

March 26, 2014

GAINESVILLE, Fla.--(BUSINESS WIRE)--Exactech President David Petty has been promoted to Chief Executive Officer effective immediately. Dr. Bill Petty, co-founder and CEO of the company since 1985, was named Executive Chairman.

March 26, 2014

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Ambry Genetics (“Ambry”) announces the launch of ExomeNext™ and ExomeNext-Rapid™ at the American College of Medical Genetics (ACMG) conference today in Nashville. The new assays feature lower turnaround times...

March 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--The FDA approved revised prescribing information for the use of Thyrogen® (thyrotropin alfa for injection) to widen the dose range of radioiodine (RAI) when used for thyroid remnant ablation.

March 26, 2014

MUNDELEIN, Ill.--(BUSINESS WIRE)--Medline debuts Revitalon, a biologic wound covering made of human amniotic tissue. Product provides structure to help heal chronic wounds including those at risk of amputations.

March 26, 2014

STRASBOURG, France--(BUSINESS WIRE)--Regulatory News: Transgene SA (Paris:TNG) announced today its financial results for the fiscal year ended December 31, 2013 and provided a business update. Highlights from the consolidated financial results...

March 26, 2014

LEXINGTON, Mass.--(BUSINESS WIRE)--Scientists at CBSET, a not-for-profit preclinical research institute dedicated to biomedical research, education, and advancement of medical technologies, are reminding thought leaders in renal denervation that...

March 26, 2014

WASHINGTON--(BUSINESS WIRE)--If left unchanged, the Obama administration’s proposal to slash use of biofuels in 2014 would increase emissions of greenhouse gases next year, according to a new white paper from the Biotechnology Industry...

March 26, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Tobira Therapeutics, a clinical-stage biopharmaceutical company advancing cenicriviroc (CVC) in liver disease and HIV, announced today that Laurent Fischer, MD, Tobira’s Chairman of the Board, has...

March 26, 2014

NEW YORK--(BUSINESS WIRE)--Actinium Pharmaceuticals began trading on the NYSE MKT today under the symbol "ATNM". The company believes this will provide added visibility in the US and international markets.

March 26, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--(Booth # 1343) – Corindus Vascular Robotics, the leader in precision vascular robotics, will showcase its FDA-cleared CorPath System at the upcoming American College of Cardiology (ACC) annual meeting, March 29 –...

March 26, 2014

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--CytomX Therapeutics, the Probody™ therapeutics company, today announced that preclinical and translational data from its novel Jagged program will be presented during poster sessions at the American...

March 26, 2014

BRIDGEWATER, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (NVDL.PK) is in the process of selling its assets in anticipation of liquidating the company and distributing its remaining cash to shareholders.

March 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics (NASDAQ: SRPT), a developer of innovative RNA-based therapeutics, announced today that it is scheduled to present at the 2014 Annual Needham Healthcare Conference.

March 26, 2014

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (NASDAQ:BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that Dr. Ulrich W. Mueller has joined the Company as...

March 26, 2014

CONCORD, Calif.--(BUSINESS WIRE)--Cerus Corporation (NASDAQ: CERS) announced today that the Humanitarian Foundation Swiss Red Cross has granted funds to Swiss Tranfusion SRC (Blutspende SRK Schweiz) to adapt the INTERCEPT Blood System for red...

March 26, 2014

ARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Joins Participants from Around the World in Recognizing Purple Day® to Raise Epilepsy Awareness

March 26, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--Fresenius Medical Care North America, the world’s largest provider of dialysis services, introduced its newly branded Frenova Renal Research, the first of its kind for clinical research services.

March 26, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE:PFE) announced today the top-line results from a Phase 3B study evaluating the 24-month efficacy of GENOTROPIN® (somatropin) on the height in small-for-gestational-age (SGA) children 24-30 months old....

March 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today that Genzyme, a Sanofi company, has exercised its right to purchase 344,448 unregistered shares of Alnylam’s...

March 26, 2014

EL PASO, Texas--(BUSINESS WIRE)--"BIEI" signs agreement on patent pending device for use with revolutionary technology for clinical trials.

March 26, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Akebia Therapeutics (AKBA) today announced the closing of its initial public offering of 6,762,000 shares of common stock at an initial public offering price of $17.00 per share.

March 26, 2014

SAN FRANCISCO--(BUSINESS WIRE)--Giant Creative/Strategy, LLC, the largest full-service independent healthcare advertising agency on the West Coast, is an Agency of the Year finalist, Category II for Med Ad News’ 25th Anniversary Manny Awards....

March 26, 2014

LANCASTER, Calif.--(BUSINESS WIRE)--Simulations Plus releases version 7 of its best-in-class ADMET Predictor property prediction software with a new model for prediction of ionization constants (pKa) from major collaboration with Bayer.

March 26, 2014

COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR), the leading stem cell company focused on developing and marketing products to treat conditions in wound care, orthopedic and sports medicine markets, is pleased to announce...

March 26, 2014

DUBLIN, Ohio--(BUSINESS WIRE)--Navidea collaborators from the Department of Nuclear Medicine at University Hospital of Leipzig are presenting highlights of PET imaging agent, NAV4694, at the German Society of Nuclear Medicine.

March 26, 2014

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Insmed Incorporated (Nasdaq GS:INSM) today reported results from the Company’s phase 2 clinical trial of ARIKAYCETM, or liposomal amikacin for inhalation, for the treatment of patients with treatment...

March 26, 2014

BUNNIK, Netherlands--(BUSINESS WIRE)--AM-Pharma announces positive Phase I data on recAP, for Acute Kidney Injury. Trial shows recAP to be safe and well tolerated at maximum dose, and ready for Phase II development

March 26, 2014

--(BUSINESS WIRE)--BioFlorida Latin America & Caribbean Life Sciences international Conference will provide attendees with an opportunity to explore business collaborations and share best practices. March 27-28 Miami.

March 26, 2014

UPPSALA, Sweden--(BUSINESS WIRE)--Regulatory News: Biotage AB (STO:BIOTA): The shareholders in Biotage AB are hereby summoned to the annual general meeting (the “Meeting”), to be held on Monday, April 28, 2014, at 4.00 p.m., at the head office of...

March 26, 2014

FRANKFURT, Germany--(BUSINESS WIRE)--Anders Malm appointed Managing Director at Ecron Acunova GmbH, Germany

March 26, 2014

BUSAN, South Korea & SAN FRANCISCO & STRASBOURG, France & HONG KONG--(BUSINESS WIRE)--Regulatory News: Transgene SA (Paris:TNG), Lee’s Pharmaceutical (HKEx: 0950) and SillaJen today unveiled their late-stage clinical development plan...

March 26, 2014

SAN FRANCISCO & CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Breakout Labs, Peter Thiel’s revolving philanthropic fund that supports early-stage companies working on technological breakthroughs, and NetScientific, a global investment group...

March 26, 2014

OXFORD & NEWCASTLE, England--(BUSINESS WIRE)--e-Therapeutics announces it has received approval from MHRA to recommence recruitment of new patients into its ETS2101 phase Ia solid tumours trial being conducted at three centres in the UK.

March 25, 2014

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization & Indiana Health Industry Forum commend Gov. Pence for signing legislation today to create a pathway for the substitution of interchangeable biologic medicines.

March 25, 2014

SAN ANTONIO--(BUSINESS WIRE)--SwRI to continue development of nasal-delivery, first-line treatment system to combat cyanide poisoning.

March 25, 2014

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10 a.m. EDT on Monday, May 5, 2014. The purpose of the call is to provide an update...

March 25, 2014

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer, Inc.,today announced that several of its innovative products will be showcased at the Analytica 2014 conference in Munich.

March 25, 2014

MENLO PARK, Calif. & SAN DIEGO--(BUSINESS WIRE)--PaxVax Inc., a specialty vaccine company focused on travelers and biodefense markets with a social mission to ensure global access to its vaccines, today announced that Kenneth Kelley, Chief...

March 25, 2014

WATERTOWN, Mass.--(BUSINESS WIRE)--Dicerna Pharmaceuticals, Inc. (NASDAQ: DRNA), a leader in the development of RNAi-based therapeutics, today announced that Douglas M. Fambrough, PhD, the Company’s President and CEO, is scheduled to present at...

March 25, 2014

BURLINGTON, Mass.--(BUSINESS WIRE)--Dyax Corp. (NASDAQ: DYAX) today announced that the underwriters of its previously announced public offering have exercised in full their option to purchase an additional 1,200,000 shares of Dyax's common stock...

March 25, 2014

SAN DIEGO & VANCOUVER, British Columbia--(BUSINESS WIRE)--Sophiris Bio Inc., (NASDAQ:SPHS) a biopharmaceutical company developing a clinical stage, targeted treatment for BPH, is presenting at the Needham Healthcare Conference on Tues, April...

March 25, 2014

DANBURY, Conn.--(BUSINESS WIRE)--IMS Health plans to post for note holders its full-year 2013 financial results on Monday, March 31, 2014. The company will conduct a conference call for IMS Health’s note holders to review these results at 1:00 p....

March 25, 2014

WASHINGTON--(BUSINESS WIRE)--Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO) issued the following statement in tribute to Dr. Norman E. Borlaug March 25 dedication.

March 25, 2014

MURRAY HILL, N.J.--(BUSINESS WIRE)--C. R. Bard, Inc. (NYSE: BCR) today announced that it will present at the Needham Healthcare Conference in New York City on April 8, 2014. Timothy M. Ring, chairman and chief executive officer, will discuss the...